CHICMAX (02145) expects to achieve a mid-term revenue of approximately 3.718 billion to 3.759 billion yuan.

CHICMAX (02145) announced that the Group expects (i) revenues for the six months ending June 30, 2026, to be between approximately RMB 3.718 billion and RMB 3.759 billion, representing a decrease of approximately 9.5% to 8.5% compared to revenues of about RMB 4.108 billion for the six months ending June 30, 2025; and (ii) profits for the Company for the six months ending June 30, 2026, to be between approximately RMB 120 million and RMB 130 million, representing a decrease of approximately 78.4% to 76.6% compared to profits of about RMB 556 million for the six months ending June 30, 2025. According to currently available information, the decrease in revenue is mainly attributed to a decline in sales revenue of the scientific anti-aging skincare brand Han Shu, which has a high revenue proportion for the Group, impacted by temporary market factors; simultaneously, the decline in Han Shu's revenue has correspondingly reduced the gross profit contribution of this brand to the Group; and the profit decline is also due to the Group's ongoing investments in human resources, research and development, and brand initiatives based on long-term strategic planning to support the sustainable development of a multi-brand matrix. Since July 2026, Han Shu's sales revenue has shown a gradually recovering trend.